Abstract 2912: INBRX-130, a 5T4-targeted CONTRA-MAB, is a potent CD3 bispecific antibody engineered to have minimal off-tumor activity
Willis, Katelyn M., Haerr, Margaret, Meza, Marchelle, Ahn, Sae Jeong, Kaplan, Michael, Ortiz-Barquero, Georgina, Pandit, Rajay, Abalos, Rafael, Chen, Yao, Holley, Samuel, Lozano, Raul, Hwang, Iljin, Rowell, Emily, Eckelman, Brendan P.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article